COVID-19 and elite sport: Cardiovascular implications and return-to-play.
|Authors||Faghy, M., Ashton REM, Parizher, G., Smith, A., Arena, R., Gough, L. A. and Emery, M. S.|
Curtailing elite sports during the coronavirus disease 2019 (COVID-19) pandemic was necessary to prevent widespread viral transmission. Now that elite sport and international competitions have been largely restored, there is still a need to devise appropriate screening and management pathways for athletes with a history of, or current, COVID-19 infection. These approaches should support the decision-making process of coaches, sports medicine practitioners and the athlete about the suitability to return to training and competition activities. In the absence of longitudinal data sets from athlete populations, the incidence of developing prolonged and debilitating symptoms (i.e., Long COVID) that affects a return to training and competition remains a challenge to sports and exercise scientists, sports medicine practitioners and clinical groups. As the world attempts to adjust toward 'living with COVID-19' the very nature of elite and international sporting competition poses a risk to athlete welfare that must be screened for and managed with bespoke protocols that consider the cardiovascular implications for performance.
|Keywords||COVID-19; Elite sport ; Cardiovascular implications ; Performance|
|Journal||Progress in Cardiovascular Diseases|
|Journal citation||76, pp. 1-9|
|Digital Object Identifier (DOI)||https://doi.org/10.1016/j.pcad.2022.11.014|
|Web address (URL)||https://www.sciencedirect.com/science/article/pii/S0033062022001359|
|Publication dates||01 Dec 2022|
|Publication process dates|
|Deposited||24 May 2023|
0views this month
0downloads this month